{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:12:35Z","timestamp":1794852755532,"version":"4.9.1"},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,4,13]],"date-time":"2007-04-13T00:00:00Z","timestamp":1176422400000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim:\u2002<\/jats:bold> To determine whether serum prostate\u2010specific antigen (PSA) levels are increased in polycystic ovary syndrome (PCOS) and the possibility of PSA to be used as a diagnostic marker of hyperandrogenism in females.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> A total of 43 women with PCOS and 43 age\u2010matched healthy females were recruited in this prospective case\u2010control study. The subjects were compared by means of demographic parameters, hormonal and metabolic measures and serum PSA levels. The correlations between this marker and a wide variety of hormonal, biochemical, anthropometric measures were evaluated. Student's <jats:italic>t<\/jats:italic>\u2010test, \u03c7<jats:sup>2<\/jats:sup>\u2010test and Spearman's correlation analysis were used for the statistical analysis where appropriate. Statistical significance was assumed with a value of <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Mean body mass index, waist\/hip ratio, Ferriman\u2013Gallwey scores (FG), lutenizing hormone\/follicle stimulating hormone ratio, insulin resistance, serum triglycerides and very low density lipoprotein levels were demonstrated to be significantly higher in PCOS (<jats:italic>P<\/jats:italic>\u2003= 0.02, <jats:italic>P<\/jats:italic>\u2003=\u20030.008, <jats:italic>P<\/jats:italic>\u2003\u2264\u20030.001, <jats:italic>P<\/jats:italic>\u2003\u2264\u20030.001, <jats:italic>P<\/jats:italic>\u2003=\u20030.007, <jats:italic>P<\/jats:italic>\u2003\u2264\u20030.001, <jats:italic>P<\/jats:italic>\u2003=\u20030.01, respectively). Total testosterone (TT), dehydroepiandrosteronesulfate (DHEAS) levels appeared to be significantly higher in PCOS (<jats:italic>P<\/jats:italic>\u2003= 0.002, <jats:italic>P<\/jats:italic>\u2003\u2264\u20030.001, respectively). Serum PSA levels were found to be significantly higher in PCOS (PSA: 0.026\u2003\u00b1\u20030.023\u2003ng\/mL in PCOS, PSA: 0.009\u2003\u00b1\u20030.008\u2003ng\/mL in control cases, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). Sex hormone binding globulin (SHBG) was significantly lower in the subjects with PCOS (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). Additionally, positive correlations between PSA and FG scores (<jats:italic>r<\/jats:italic>: 0.417, <jats:italic>P<\/jats:italic>\u2003\u2264\u20030.001), PSA and TT (<jats:italic>r<\/jats:italic>: 0.456, <jats:italic>P<\/jats:italic>\u2003=\u20030.03) and between PSA and DHEAS (<jats:italic>r<\/jats:italic>: 0.268, <jats:italic>P<\/jats:italic>\u2003=\u20030.02) were found. A negative correlation between SHBG and PSA was apparent (<jats:italic>r<\/jats:italic>\u2003: \u22120.40, <jats:italic>P<\/jats:italic>\u2003=\u20030.04).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> PSA is a well\u2010established tumor marker of prostatic adenocarcinoma. It is also shown to be produced by extraprostatic tissues and fluids. As the gene expression of PSA is upregulated by the androgens and progestins in hormonally responsive tissues, hyperandrogenic syndromes such as PCOS may be associated with elevated serum PSA levels. PSA appears to be a promising marker of endogenous androgen excess in females suffering from PCOS.<\/jats:p>","DOI":"10.1111\/j.1447-0756.2007.00507.x","type":"journal-article","created":{"date-parts":[[2007,4,13]],"date-time":"2007-04-13T14:26:24Z","timestamp":1176474384000},"page":"166-173","source":"Crossref","is-referenced-by-count":16,"title":["Is prostate\u2010specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?"],"prefix":"10.1111","volume":"33","author":[{"given":"Birol","family":"Vural","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebiha","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harika","family":"Bodur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,13]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70238-8"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(03)00735-0"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.4.1558"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000184145"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.9.3030"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(03)00733-7"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1016294"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.18.6.774"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.7.2580"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03344101"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990215)85:4<891::AID-CNCR17>3.0.CO;2-K"},{"key":"e_1_2_5_13_2","first-page":"415","article-title":"Steroid hormone regulation of prostate\u2010specific antigen gene expression in breast cancer","volume":"43","author":"Zarghami N","year":"1997","journal-title":"Br J Cancer"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(97)00171-9"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65328-X"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.9.3313"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/clinchem\/46.6.859","article-title":"Serum and urinary prostate\u2010specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female\u2010to\u2010male transexuals","volume":"46","author":"Obiezu CV","year":"2000","journal-title":"Clin Chem"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590410001692465"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-21-11-1440"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(81)90746-8"},{"key":"e_1_2_5_22_2","volume-title":"Physical Status: The Use and Interpretation of Anthropometry.","author":"WHO Expert Committee.","year":"1995"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92552-8"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2002.31975"},{"key":"e_1_2_5_25_2","first-page":"182","article-title":"An update on diagnostic criteria for diabetes and the metabolic syndrome","volume":"5","author":"Lepor NE","year":"2004","journal-title":"Rev Cardiovasc Med"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.8.2694"},{"key":"e_1_2_5_27_2","first-page":"3983","article-title":"Prostate\u2010specific antigen\u2010new applications in breast and other cancers","volume":"16","author":"Diamandis EP","year":"1996","journal-title":"Anticancer Res"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(05)70373-6"},{"key":"e_1_2_5_29_2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/clinchem\/42.5.675","article-title":"Ultrasensitive detection of prostate\u2010specific antigen by a time resolved immunofluorometric assay and the Immulite immunochemiluminescent third generation assay: potential applications in prostate and breast cancers","volume":"42","author":"Ferguson R","year":"1996","journal-title":"Clin Chem"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006304518750"},{"key":"e_1_2_5_31_2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/clinchem\/42.6.853","article-title":"Ultrasensitive prostate\u2010specific antigen assays and their clinical application","volume":"42","author":"Diamandis EP","year":"1996","journal-title":"Clin Chem"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.01822.x"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.3.777"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90077-9"},{"key":"e_1_2_5_35_2","first-page":"31","article-title":"Changes of PSA concentrations in serum and saliva of healthy women during the menstrual cycle","volume":"32","author":"Aksoy H","year":"2002","journal-title":"Ann Clin Lab Sci"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.1.81"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(97)81362-3"},{"key":"e_1_2_5_38_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000474724","article-title":"The \u2018female prostate\u2019. Location, morphology, immunohistochemical characteristics and significance","volume":"22","author":"Wernert N","year":"1995","journal-title":"Eur Urol"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1447-0756.2007.00507.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1447-0756.2007.00507.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T22:49:15Z","timestamp":1697323755000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1447-0756.2007.00507.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1111\/j.1447-0756.2007.00507.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1447-0756.2007.00507.x","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}